- Home
- ADXN vs ADN Comparison
ADXN vs ADN Comparison
Compare ADXN & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- ADN
- Stock Information
- Founded
- ADXN 2002
- ADN 2006
- Country
- ADXN Switzerland
- ADN United States
- Employees
- ADXN N/A
- ADN N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- ADXN Health Care
- ADN Utilities
- Exchange
- ADXN Nasdaq
- ADN Nasdaq
- Market Cap
- ADXN 8.1M
- ADN 7.5M
- IPO Year
- ADXN N/A
- ADN N/A
- Fundamental
- Price
- ADXN $8.12
- ADN $2.46
- Analyst Decision
- ADXN Strong Buy
- ADN
- Analyst Count
- ADXN 1
- ADN 0
- Target Price
- ADXN $30.00
- ADN N/A
- AVG Volume (30 Days)
- ADXN 3.0K
- ADN 46.6K
- Earning Date
- ADXN 06-05-2025
- ADN 12-27-2024
- Dividend Yield
- ADXN N/A
- ADN N/A
- EPS Growth
- ADXN N/A
- ADN N/A
- EPS
- ADXN 0.06
- ADN N/A
- Revenue
- ADXN $701,260.00
- ADN $8,157,000.00
- Revenue This Year
- ADXN N/A
- ADN $2,232.99
- Revenue Next Year
- ADXN N/A
- ADN $91.56
- P/E Ratio
- ADXN $1.06
- ADN N/A
- Revenue Growth
- ADXN N/A
- ADN 274.35
- 52 Week Low
- ADXN $6.51
- ADN $1.71
- 52 Week High
- ADXN $13.27
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- ADXN 54.21
- ADN 42.46
- Support Level
- ADXN $7.70
- ADN $2.60
- Resistance Level
- ADXN $8.38
- ADN $2.85
- Average True Range (ATR)
- ADXN 0.32
- ADN 0.40
- MACD
- ADXN 0.01
- ADN 0.07
- Stochastic Oscillator
- ADXN 59.13
- ADN 28.37
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.